Shareholders' Equity - Options Granted (Details) (USD $)
In Thousands, except Share data, unless otherwise specified |
3 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|
Mar. 31, 2013
|
||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Vesting Period | 4 years | |||||||
January 31, 2012
|
||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Grant Date | Jan. 28, 2013 | [1],[2] | ||||||
Expire Date | Jan. 28, 2023 | |||||||
Shares | 25,000 | |||||||
Exercise Price | 1.40 | |||||||
Fair Value | 23 | [3] | ||||||
May 29, 2012
|
||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Grant Date | Jan. 28, 2013 | [1] | ||||||
Expire Date | Jan. 28, 2023 | |||||||
Shares | 2,235,000 | |||||||
Exercise Price | 1.40 | |||||||
Fair Value | 1,585 | [3] | ||||||
July 12, 2012
|
||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Grant Date | Feb. 20, 2013 | [1] | ||||||
Expire Date | Feb. 20, 2023 | |||||||
Shares | 10,000 | |||||||
Exercise Price | 1.40 | |||||||
Fair Value | 7 | [3] | ||||||
|